The coronavirus (COVID-19) epidemic has escalated into a pandemic and is giving companies serious pause for thought on a number of fronts, including employment law, contract and supply chain risks and force majeure situations.
In order to provide rapid help to our clients in dealing with the epidemic, we have put together a new service, the C&S Coronavirus Task Force, which consists of our experts in coronavirus issues in numerous fields of law.
Our clients can contact their responsible lawyers or contact the Corona Task Force experts directly through coronataskforce@castren.fi.
CLIENT SERVICES AVAILABLE AS NORMAL
We will continue to provide our services as normal despite the epidemic. We have taken the following steps to account for the current circumstances:
• We can work with clients remotely, e.g. arrange remote meetings. We have instructed our personnel to work remotely as much as possible.
• We have postponed our client events and seminars. We will notify everyone who has registered for our events directly.
• We respectfully ask that everyone visiting our offices takes care of their hand hygiene and avoids shaking hands.
We are monitoring the situation closely and are complying with the latest authority instructions.
We have several blog posts on our website about the possible impacts of the coronavirus on business from the perspective of Finnish law.
Coronavirus – Secure Your Business-Critical Issues
What Would the Emergency Powers Act Mean for Life Insurance Policies?
Latest news
Latest references
Cibus Real Estate – Acquisition of three retail properties
We advised Cibus Real Estate AB (publ) on its acquisition of three newly built retail properties in Pori, Finland. Kesko is the tenant in all three properties, and the average lease term is 8.1 years. Cibus is a real estate company listed on Nasdaq Stockholm Mid Cap. The company’s business concept is to acquire, develop and manage properties in Europe with daily goods chains as anchor tenants. The company currently owns approximately 700 properties in Europe.
Case published 12.11.2026
Seaya Nova and Molten Ventures – USD 80 million series C financing of Pliant
We advised Seaya Nova and Molten Ventures as Finnish counsel in connection with the USD 80 million Series C financing of Pliant, a Berlin-based fintech specialising in B2B payment solutions and corporate credit cards. The financing round was led by Seaya Nova and Speedinvest, with participation from Illuminate Financial, Motive Partners, Molten Ventures and Citi Ventures. Founded in Berlin in 2020, Pliant provides modular payment solutions for businesses and holds an EU e-money licence in Finland as well as a licence from the UK Financial Conduct Authority. We advised on the Finnish law aspects of the transaction alongside YPOG, which acted as lead counsel to Seaya Nova and Molten Ventures.
Case published 12.11.2026
Nala Renewables – Development, acquisition and financing of battery energy storage system (BESS) project
We advised Nala Renewables on the Finnish law aspects of the development, acquisition and financing of its battery energy storage system (BESS) project in Vuolijoki, Finland. The project comprises a 125 MW / 250 MWh battery energy storage system. Our advice extended beyond financing to the transaction’s legal due diligence and the acquisition of the project company. We also advised on key project contracts and financing documentation for the project finance facilities provided by Coöperatieve Rabobank U.A. The project is part of Nala Renewables’ growing portfolio of battery storage assets in Finland and the wider Nordic region, supporting the integration of renewable energy and contributing to the flexibility and stability of the Finnish electricity grid.
Case published 3.11.2026
Foundation Clinic – Funding Round
We advised Foundation Clinic in connection with its funding round backed by a group of prominent Finnish technology entrepreneurs and investors, including founders behind Supercell and Wolt. Foundation Clinic is a Finnish healthcare company developing a new approach to private healthcare focused on preventive, data-driven and continuous care. The company aims to combine comprehensive health data with ongoing medical care to identify and address health risks at an early stage.
Case published 29.10.2026